


























































The Impact of Halogenated Phenylalanine Derivatives on
NFGAIL Amyloid Formation
Suvrat Chowdhary,[a] Johann Moschner,[a] Dorian J. Mikolajczak,[a] Maximilian Becker,[b]
Andreas F. Thünemann,[c] Claudia Kästner,[c] Damian Klemczak,[d] Anne-Katrin Stegemann,[a]
Christoph Böttcher,[e] Pierangelo Metrangolo,[f] Roland R. Netz,[b] and Beate Koksch*[a]
The hexapeptide hIAPP22–27 (NFGAIL) is known as a crucial
amyloid core sequence of the human islet amyloid polypeptide
(hIAPP) whose aggregates can be used to better understand
the wild-type hIAPP’s toxicity to β-cell death. In amyloid
research, the role of hydrophobic and aromatic-aromatic
interactions as potential driving forces during the aggregation
process is controversially discussed not only in case of NFGAIL,
but also for amyloidogenic peptides in general. We have used
halogenation of the aromatic residue as a strategy to modulate
hydrophobic and aromatic-aromatic interactions and prepared
a library of NFGAIL variants containing fluorinated and
iodinated phenylalanine analogues. We used thioflavin T
staining, transmission electron microscopy (TEM) and small-
angle X-ray scattering (SAXS) to study the impact of side-chain
halogenation on NFGAIL amyloid formation kinetics. Our data
revealed a synergy between aggregation behavior and hydro-
phobicity of the phenylalanine residue. This study introduces
systematic fluorination as a toolbox to further investigate the
nature of the amyloid self-assembly process.
Introduction
Native proteins can undergo misfolding and aggregation under
conditions of environmental stress.[1] A well-known example are
amyloid fibrils, which are pathological signatures of neuro-
degenerative disorders like Alzheimer’s disease (AD), Hunting-
ton’s disease (HD), Parkinson’s disease (PD) and type II diabetes
(T2D).[2] In case of T2D, the human islet amyloid polypeptide
(hIAPP) aggregates into highly structured amyloid plaques.[3] It
is suspected, that hIAPP’s toxicity is related to a disruption of
the cell membrane of insulin-producing β-cells within the
pancreas induced by transient oligomeric aggregates.[4] Several
reports studied the complex nature of membrane-associated
amyloid formation causing β-cell dysfunction in order to
understand the correlation between amyloid growth and cell
damage.[5] Thus, an in-depth understanding of the nucleation
process of amyloid fibrils is of paramount importance to enable
the development of efficient techniques for regulating their
kinetics. In 1990, Westermark et al. reported that IAPP-derived
amyloids are only formed by humans, cats, and some non-
human primates and not observed in case of rodents possess-
ing the rat sequence rIAPP which differs by six amino acids
mostly located in the region of residue 20–29.[6] Initial studies
revealed hIAPP’s amyloidogenicity substantiated in the 20–29
region since the sequence hIAPP20–29 (SNNFGAILSS) exposed an
amyloidogenic behavior, whereas rIAPP20–29 (SNNLGPVLPP) does
not form fibrils.[7] Interestingly, Brender et al. studied these
sequences in context of membrane disrupting effects and
observed membrane fragmentation due to interaction of
hIAPP20–29 (SNNFGAILSS) with phospholipid bilayers.
[5b] Tenidis
et al. explored the hexamer hIAPP22–27 (NFGAIL) as amyloid core
domain, which is assembling into β-sheet-containing amyloid
fibrils and possesses a similar cytotoxicity towards the pancre-
atic cell line RIN5fm as the full-length protein.[8] Among many
theoretical[9] and experimental studies[10] about the importance
of aromatic residues in amyloid formation, an alanine-scanning
mutagenesis experiment[10c] indicated attractive interactions
between phenylalanine residues as main driving forces. In
addition, previous studies described the onset of early NFGAIL-
oligomers by use of ion mobility-mass spectrometry combined
with gas-phase IR spectroscopy.[11] Recent articles in amyloid
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research[12] highlighted the utilization of computational meth-
ods to explore the nature of amyloidogenic peptides. In
particular, conformational and structural changes of Aβ1–42 due
to its interaction with toxic gas like CO2 and NO2
[13] were
reported, but also the investigation of membrane binding
behaviors of Aβ17–42 in different oligomeric states using coarse-
grained (CG) MD simulations.[14]
Selective incorporation of fluorinated amino acids is known
as a powerful tool to fine-tune biophysical and chemical
properties of peptides and proteins.[15] This type of protein
engineering has been exploited as a tool to study, for instance,
amyloid fibrillogenesis in real-time by 19F NMR spectroscopy
combined with CD spectroscopy as reported for the peptides
Aβ1–40
[16] and hIAPP.[17] Incorporation of fluorinated amino acids
into amyloidogenic peptides enables to define its impact on
the overall fibril structure by probing 19F–19F distances by solid-
state 19F NMR spectroscopy.[15d] In general, fluorine has shown
to alter important features like hydrophobicity, proteolytic
stability and secondary structure propensity of respective amino
acids, but this alteration is still difficult to predict.[15d,18] On the
other hand, H  F substitution of a phenylalanine side chain
leads to a rearrangement of the electrostatic potential (ESP)
and, in extreme cases, reverses the quadrupole moment of
aromatic systems.[19] This strategy can be used to further
elucidate the aggregation process, yet reports of its impact are
scarce. The impact of aromatic fluorinated amino acids in
amyloid formation was studied by substitution of Phe in
hIAPP20–29 (SNNFGAILSS) and hIAPP22–29 (NFGAILSS).
[20] Mono-
fluorination at para-position[20b] and, ultimately, perfluorination
of the aromatic side chain[20] in these model peptides led to
faster aggregation kinetics. However, whether the amyloidoge-
nicity of aromatic residues is due to high hydrophobicity or
formation of stabilizing π  π interactions is controversially
discussed.[20b,21]
Thus, the state of the art in this field of research called for a
systematic study regarding the impact of the aromatic residue
on the kinetics of NFGAIL amyloid formation. Our approach was
to introduce fluorine and iodine substituents in different
numbers and positions into the Phe residue of NFGAIL. A library
of NFGAIL variants was prepared, in which Phe is systematically
substituted with the selected symmetrical halogenated building
blocks [4F]Phe, [3.5F]Phe, [2.3.5.6F]Phe, [2.3.4.5.6F]Phe and
[2.3.5.6F][4I]Phe. These sequences were studied by employing
thioflavin T fluorescence assays, transmission electron micro-
scopy (TEM) and small-angle X-ray scattering (SAXS).
Results and Discussion
Design of halogenated NFGAIL variants
Although the replacement of carbon-bonded hydrogen with
fluorine is generally considered to be isosteric,[22] incorporation
of fluorinated amino acids has shown to drastically change the
chemical properties of peptides and proteins.[15c,18a] To the best
of our knowledge, a hydrophobicity scale for fluorinated
analogues of aromatic amino acids a has not been reported yet.
In order to establish a suitable indicator of hydrophobicity for
the here studied phenylalanine derivatives (Figure 1a), we
introduced a condensed-phased plot (Figure 1b) generated by
comparison of the retention time of both Fmoc-protected
natural and fluorinated amino acids as part of a standardized
HPLC assay correlated to computed vdW volumes of their side
chains.[23] Also, we calculated corresponding MlogP values for
Phe, [4F]Phe, [2.3.5.6F]Phe, [2.3.4.5.6F]Phe and [2.3.5.6F][4I]Phe
as published by Moriguchi et al. (Figure 1c).[24] Both the
experimentally determined hydrophobicity scale (Figure 1b)
and the calculated MlogP plot (Figure 1c) confirm an out-
standing shift in hydrophobicity and size of the side chain of
Phe due to fluorination as shown in Figure 1b, while the extent
of fluorination determines the dimension of the change. The
presented fluorinated Phe variants can be classified as “partially
fluorinated” and “perfluorinated”.
According to the condensed-phased RP-HPLC-assay, parti-
ally fluorinated analogues [4F]Phe [tR (HPLC-assay): 15.44 min],
[3.5F]Phe [tR (HPLC-assay): 16.15 min] and [2.3.5.6F]Phe [tR
(HPLC-assay): 15.81 min] show enhanced hydrophobicity com-
pared to Phe [tR (HPLC-assay): 14.38 min] but comparatively
small differences to themselves, whereas a stronger increase is
observed in case of [2.3.5.6F]Phe [tR (HPLC-assay): 18.57 min]
and its iodinated analogue [2.3.5.6F][4I]Phe [tR (HPLC-assay):
19.99 min]. The latter exhibits the most hydrophobic character
combined with the highest vdW volume among all studied Phe
variants. Furthermore, recent investigations provided exper-
imental evidence for 4-iodotetrafluorophenylalanine to act as
halogen bond-donor, which could also affect amyloid
formation.[25] Interestingly, a consistent correlation between a
growing degree of side-chain halogenation and increasing
hydrophobicity is not fully accounted in case of [2.3.5.6F]Phe.
While the HPLC assay depicts slightly weaker hydrophobic
properties of the tetrafluorinated Phe variant in contrast to
[3.5F]Phe, their M logP values appoint an succinctly opposite
trend. This is not surprising, since significant differences
between both scales exist as they are based on different
principles.[26] To overcome this limitation, our group was
recently involved in the development of a universal hydro-
phobicity scale based on clustering of amino acids in the gas
phase revealing a unique behavior of fluorinated Phe variants
by a decrease in hydrophobicity compared to Phe.[27]
Besides hydrophobicity, π  π interactions have been pro-
posed to play a significant role during amyloid formation in
general but several conflicting reports about their importance
exist.[21,28] These interactions can be defined as a sum of the
interplay between aromatic side chains involving hydrophobic,
van der Waals, and also electrostatic forces.[29] They are based
on specific types of geometries (face-face/edge-face) that differ
by the angle between two rings and their offset value
(Figure 2a).[28b,c] Experimental studies showed a very low
amyloidogenic potential in case of the related sequence
NYGAILSS and explained this circumstance through a disruption
in face-face-stacking by the substitution of Phe with Tyr, as
molecular dynamics simulations predicted mainly edge-face
interactions for Tyr-Tyr pairs.[30] In contrast, substitution of Phe
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behavior.[28a] Herein, the fine-tuned electron density in selected
fluorinated phenylalanine analogues allows to gain a deeper
insight into occurrences and geometries of aromatic–aromatic
interactions in NFGAIL amyloid formation. Calculated electro-
static potential maps of [2.3.5.6F]Phe (Figure 2b,[4]) and
[2.3.4.5.6F]Phe (Figure 2b,[5]) highlight the edge-face interaction
as favored geometry for the tetrafluorinated variant during
amyloid formation, whereas face-face stacking is expected for
the perfluorinated derivative as previously reported for native
phenylalanine.[9a,30b,31] It was concluded that the electrophilic H-
atom of [2.3.5.6F]Phe at para-position could retard the preorga-
nization of amyloid formation kinetics by occupying an edge-
face geometry, whereas incorporation of the perfluorinated Phe
variant [2.3.5.6F]Phe would result in a face-face geometry during
NFGAIL nucleation. It must be mentioned that during NFGAIL
self-assembly, aromatic–aromatic interactions are proposed to
act as a tool for preorganization in molecular recognition
processes, particularly the association to oligomeric nuclei.
Investigation of this part of the self-assembly process gives
important information about amyloid nucleation, while struc-
tural characterization can define a possible aryl-aryl geometry in
solid fibrils formed during the saturation phase. Based on MD
simulations[32] and X-ray crystallography experiments[10a] Guo
and co-workers and Eisenberg and co-workers reported for
hIAPP22–29 (NFGAILSS) an orientation of cross-β pattern in the
fibril with interactions between Phe and Ile residues of opposite
strands. Furthermore, Nielsen and co-workers used solid-state
NMR spectroscopy to determine a supramolecular structure for
hIAPP20–29 (SNNFGAILSS) based on an antiparallel steric zipper
type with interacting Phe and Leu residues between two
neighboring β-sheets as well as between Phe and Ile of the
opposite β-sheet strands.[33]
Thioflavin T fluorescence assay for the detection of NFGAIL
amyloid formation
The hexapeptide NFGAIL is capable to form amyloid fibrils at
neutral pH.[8] Kinetics of fibril formation were monitored in real-
time using thioflavin T staining. We used this method for
defining amyloid formation kinetics of the corresponding
NFGAIL variants N-[4F]Phe-GAIL (Figure 3a), N-[3.5F]Phe-GAIL
(Figure 3b), N-[2.3.5.6F]Phe-GAIL(Figure 3c), N-[2.3.5.6F]Phe-GAIL
(Figure 3d) and N-[2.3.5.6F][4I]Phe-GAIL (Figure 3e). During the
lag time, early nuclei formation takes place. An initial step of
nucleation consists in the slow and reversible association of
monomers. This thermodynamically unfavorable self-assembly
process has a high-energy barrier and is the rate-limiting step
Figure 1. a) Peptide library of halogenated NFGAIL variants. The Phe residue is substituted with the given fluorinated/iodinated analogues. b) Retention times
(RP-HPLC assay) of Fmoc-protected amino acids plotted against the vdW volume of their side chains. Phe and its halogenated analogues are represented in
red, whereas further native Fmoc-protected amino acids are appearing as black triangles for comparison. The retention time (tR) of amino acids acts as an
experimentally defined dimension of hydrophobicity. c) Hydrophobicity plot based on MlogP values of native Phe [M logP:   1.374],[4F]Phe [MlogP:
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during the entire aggregation event.[34] All ThT curves show
sigmoidal aggregation profiles as a typical feature of nuclea-
tion-dependent polymerization mechanism and their lag times
are listed in Table 1.[2a,35] Recently, we examined the aggregation
kinetics of the native NFGAIL sequence and fibril formation was
detected after 20 h at 4 mM and confirmed by visualization of
NFGAIL amyloids by transmission electron microscopy.[11]
A distinctive critical concentration is an indispensable
criterion to initiate fibril formation.[36] Recent studies provided
experimental data for a critical-concentration dependency in
case of Aβ1–42 amyloid aggregation.
[37] In contrast, Brender et al.
examined the full-length polypeptide hIAPP and determined a
lack of concentration-dependency during amyloid aggregation
at low initial concentrations, but a significant acceleration in
fiber formation near a threshold concentration.[38] Our kinetic
data demonstrate a strict concentration-dependency of amyloid
formation rates. It can be concluded that the lag time of
aggregation significantly decreases with increasing concentra-
tion. Thus, a minimal concentration of 4 mM was determined
for N-[4F]Phe-GAIL and N-[3.5F]Phe-GAIL, whereas in analogous
experiments at 3 mM concentration formation of aggregates
was not detected in time scales of 20–40 h (for all selected
concentrations, see Table S1 in the Supporting Information). In
Figure 2. a) Probing the role of π  π interactions as supramolecular driving force in NFGAIL self-assembly with systematic fluorination of aromatic residues. We
experimentally studied a possible correlation between the changes in electron density distribution of incorporated phenylalanine derivatives and an alteration
of aromatic interactions dring molecular recognition in NFGAIL fibril formation. Aromatic residues predominantly occupy a stacked (face-face) or a T-shaped
(edge-face) geometry. Perturbations in π-stacking geometries were conjectured to provoke interferences in formation of continuous hydrogen-bond-directed
β-sheets and therefore affect NFGAIL aggregation kinetics. b) Electrostatic potential (ESP) maps calculated from density-functional theory on interpolated van
der Waals radius surfaces (blue means greater or equal the maximum positive potential, red means greater or equal maximum negative potential) of the side-
chains of [1]phenylalanine and its halogenated derivatives[2][4F]Phe, [3][3.5F]Phe, [4][2.3.5.6F]Phe, [5][2.3.5.6F]Phe and [6][2.3.5.6F][4I]Phe, which were
incorporated into NFGAIL.
Table 1. Lag times of halogenated NFGAIL variants determined by ThT
fluorescence staining. Errors were obtained as standard deviations of
measurements taken from independent experiments. (�SD, n=3, further
congruent curves can be found in the Supporting Information)
Sequence Conc. [mM] Lag time [h]
N-[4F]Phe-GAIL 4 6.00�0.37
N-[3.5F]Phe-GAIL 4 18.16�1.10
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comparison, the native sequence NFGAIL follows a nucleation
dependent growth mechanism at 4 mM.[11] N-[2.3.4.5.6F]Phe-
GAIL and N-[2.3.5.6F][4I]Phe-GAIL showed lower minimal con-
centrations (3 mM, 1 mM), whereas higher concentrations led to
immediate aggregation. Nevertheless, it must be mentioned
that our initial concentrations are very high compared to
experimentally defined values for the polypeptide hIAPP (0.5–
5 μM)[38] and hIAPP20–29 (SNNFGAILSS; 0.25 mM),
[33] but in
accordance to initial studies of the sequences hIAPP23–27 (FGAIL)
and hIAPP22–27 (NFGAIL; each 5 mM).
[8] Also, the nature of the
buffer has an impact on the formation of amyloids. For each of
the above-mentioned peptides different buffers were used
Figure 3. Thioflavin T assays of NFGAIL variants a) N-[4F]Phe-GAIL,[4 mM] b) N-[3.5]Phe-GAIL,[4 mM] c) N-[2.3.5.6F]Phe-GAIL[4 and 3 mM] d) N-[2.3.5.6F]Phe-
GAIL[3 mM] and e) N-[2.3.5.6F][4I]Phe-GAIL [3 and 1 mM] incubated at 37 °C with orbital shaking for 2 s (amplitude: 2 mm, frequency: 280.8 rpm) before each
measurement (10 min intervals) and dissolved in ammonium acetate (10 mM) buffer containing 20 μM thioflavin T, pH 7.0. The fluorescent dye gives a strong
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(hIAPP: 10 mM sodium phosphate buffer, 100 mM NaCl, pH 7.3/
hIAPP20–29 (SNNFGAILSS): 50 mM HEPES buffer, pH 7.2/hIAPP23–27
(FGAIL) and hIAPP22–27 (NFGAIL): 10–20 mM sodium phosphate
buffer, pH 7.4/this work [as established by Hoffmann et al.]:
10 mM ammonium acetate, pH 7.0).[8,11,33,38] As recently reported
by Brudar et al., buffer specific effects can dramatically affect
amyloid self-assembly by stabilizing or disrupting the protein
native structure, so that comparison of our results to previously
described sequences is difficult.[39]
Our fluorescence data are in accordance to conclusions of
theoretical studies and show a correlation between hydro-
phobicity and amyloid formation rate.[9a,32] N-[2.3.5.6F]Phe-GAIL
(3 mM; Figure 3d) folds into amyloids much faster than N-[4F]
Phe-GAIL (4 mM; Figure 3a). These results are consistent to
experimental studies reporting an acceleration by incorporation
of 2, 3, 4, 5, 6-pentafluorophenylalanine in cognate sequences
hIAPP20–29 (SNNFGAILSS) and hIAPP22–29 (NFGAILSS).
[20] At a
concentration of 4 mM, the tetrafluorinated variant N-[2.3.5.6F]
Phe-GAIL (Figure 3c) displayed here faster aggregation kinetics
than its monofluorinated and difluorinated derivatives. An
immediate aggregation of N-[2.3.5.6F][4I]Phe-GAIL (Figure 3e) at
a concentration of 3 mM was found, which we explain based on
its pronounced hydrophobicity, which is the strongest amount
of all here studied phenylalanine derivatives (Figure 4a–b).
Therefore, higher values of the “C  I”-bond length and atomic
size of iodine compared to fluorine could have led to sterically
demanding situations that could have disturbed the aggrega-
tion process. Beside hydrophobic interactions also halogen
bonding with, for example, the side chain of Asn or the peptide
backbone, could affect the preorganization of N-[2.3.5.6F][4I]
Phe-GAIL in solution and, thus, contribute to NFGAIL fibril
formation.
In terms of aromatic–aromatic interactions, our experimen-
tal data do not reveal further information about specific π-
stacking geometries. Opposite π-stacking modes (N-[2.3.5.6F]
Phe-GAIL= face-face/N-[2.3.5.6F]Phe-GAIL=edge-face) were not
observed to significantly affect the NFGAIL aggregation process
and, therefore, seemed to be less important for fibril formation.
It is most noteworthy that in previous studies sterically
demanding groups were reported to decelerate aggregation
kinetics.[20a] Our results surprisingly reveal an independency of
amyloid formation rate to the side chain’s size in NFGAIL fibril
formation. Moreover, we determined a significant increase in
vdW volume by incorporation of fluorine and especially iodine
and, at the same time, an acceleration of self-assembly into
distinct ordered amyloid fibrils as seen in particular for N-
[2.3.5.6F][4I]Phe-GAIL and confirmed by transmission electron
microscopy.
Modulation of aromatic σ-frameworks: Interaction energies of
fluorinated phenylalanine derivatives in water
An interesting exception is constituted by the difluorinated
NFGAIL variant N-[3,5F]Phe-GAIL (Figure 3b) which showed the
longest lag time (18.16�1.10 h) of all here studied NFGAIL
analogues. Considering its hydrophobic properties (Figure 4a–
b), incorporation of [3,5F]Phe should result in an acceleration of
NFGAIL amyloid formation compared to [4F]Phe. We assumed
the modulated σ-framework within [3,5F]Phe to possibly serve
as a diametrical effect towards the amyloid self-assembly
process. Previous computational studies about aromatic car-
bon-bound fluorine revealed the side chain of [3,5F]Phe as a
peculiar pattern by possessing two fluorine atoms able to
participate in hydrogen bonding including a very acidic
aromatic hydrogen atom at para-position.[40] In an aqueous
solution, this structure generates adjacent binding sites which
could not only facilitate C  H  O interactions known in literature
as non-classical hydrogen bonds (NCHBs), but also F  H bridges
with water molecules.[40–41] To quantify this argument, we
calculated interaction energies of water molecules with the
toluene derivatives at zero temperature using density functional
theory and post-Hartree-Fock methods. The resulting minimal
energy structures and the binding energies are shown in
Figure 5 (see computational methods for details). In case of
[3,5F]Phe, we find multiple favorable water-binding motifs,
stemming from its alternating positively and negatively charged
binding sites (Figure 2b). First, we optimized the structure of
single water molecules that interact with the fluorinated
aromatic systems, the resulting equilibrium geometries are
depicted in Figure 5a. It is seen that single water molecule
binding to partially fluorinated systems is strongly enhanced by
an alternating H  F configuration. There, the water molecule can
act as acceptor and donator at the same time (Figure 5a,[2,5]),
compared to the water molecule arranging at two fluorine
atoms (Figure 5a[6,7]). We see that [3,5F]Phe has a total of four
possible strong binding modes of the H  F type (Figure 5a,[3,4]
each counted twice with its symmetric counterpart) and thus is
suggested to have stronger interactions with water than all the
Figure 4. Lag times of halogenated NFGAIL variants were plotted against a)
the experimentally determined retention times of incorporated phenyl-
alanine derivatives and b) their calculated MlogP values. Both plots reveal a
correlation between decreased lag times and ehanced hydrophobic proper-
ties of the Phe residues due to side-chain halogenation[4F]Phe![2.3.5.6F]
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other compounds. We note that the reported interaction
energies are substantially smaller than water-water interaction
energies, which we calculated to be 17.15 kJ/mol at the chosen
level of theory for two water molecules, indicating that all
fluorinated compounds studies here are hydrophobic. The top
region of [3,5F]Phe and [2.3.5.6F]Phe with its F  H–F binding
motif allows for a specific 3-water cluster which binds to the
aromatic ring while maintaining a hydrogen bond network in
between the water molecules (Figure 5b). Therefore, we calcu-
lated interaction energies for 5-water cluster for these two
compounds. The complexation energy of the [3.5F]Phe 5-water
cluster (Figure 5b,[1]) is larger by 7.62 kJ/mol then of the
corresponding [2.3.5.6F]Phe 5-water cluster (Figure 5b,[2]), be-
cause of the additional two binding sites of H  F type at the
Figure 5. a) Various optimized water-binding geometries of [1]phenylalanine and its derivatives[2][4F]Phe, [3][4][3.5F]Phe, [5][6][2.3.5.6F]Phe and [7][2.3.5.6F]
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bottom of the structure. Comparably well-structured 5-water
clusters could not be found for the remaining compounds. The
outlined energetically favorable hydration patterns of [3.5F]Phe
could accommodate for relatively strong interactions with the
aqueous buffer, providing an explanation for the retardation of
amyloid nucleation.
Determination of the morphology of halogenated NFGAIL
fibrils by transmission electron microscopy (TEM)
For structural investigation of resulting fibrils, negative-staining
TEM images were recorded for all halogenated NFGAIL-
derivatives (Figure 6). Generally, all selected samples show
rather linear and tightly packed fibrillary structures, but a
unique morphology and diameter due to incorporation of
fluorine and iodine. N-[3,5F]Phe-GAIL formed filaments that
bundle into larger fibrils with a diameter of 168.3�27.5 nm,
whereas for N-[3,5F]Phe-GAIL (11.5�1.6 nm), N-[2.3.5.6F]Phe-
GAIL (21.3�6.2 nm), N-[2.3.5.6F]Phe-GAIL (27.3�7.7 nm) and N-
[2.3.5.6F][4I]Phe-GAIL (10.5�1.5 nm) a homogeneous structure
was found for a single unit of resulting fibrils, possessing a
largely unbranched structure. Obviously, halogenation of the
phenylalanine residue changes not only the kinetics of fibril
formation but does also affect the aggregate’s morphology.
Large fibril filaments were detected for N-[4F]Phe-GAIL, whereas
amyloids composed of N-[3,5F]Phe-GAIL with analogue concen-
trations revealed comparatively thinner fibrils, although an
opposite finding could have been expected with regards to the
higher vdW volume of [3,5F]Phe compared to [4F]Phe. As the
mechanisms of amyloid formation in general are still not fully
understood due to the complexity of occurring processes within
amyloid fibril formation,[3d,42] detailed interpretations of the
structure of amyloids based on TEM images are not possible.
Therefore, high-resolution structural studies could provide
further fundamental information about the role of aromatic
interactions in amyloid fibril formation of these NFGAIL variants.
Small-angle X-ray scattering experiments were proceeded
for the native NFGAIL sequence and its fluorinated variants N-
[2.3.5.6F]Phe-GAIL and N-[2.3.5.6F]Phe-GAIL (for full SAXS analy-
sis; Figures S37 and S38). As a result, the amyloid fibrils
obtained from both native and fluorinated sequences seem to
possess a ribbon-like appearance and are comparable to the
values as published for a parallelepiped by Langkilde et al.[43]
Conclusion
In this study, we presented a series of fluorinated and iodinated
analogues of the amyloidogenic model peptide NFGAIL derived
from the human islet amyloid polypeptide (hIAPP). We used
selective halogenation as a tool to fine-tune the biophysical
properties and size of the aromatic residue. As shown through a
HPLC-based assay (Figure 1a), calculated MlogP values (Fig-
ure 1b) and ESP maps (Figure 2b), fluorination of the aromatic
side- chain leads to an alteration in hydrophobicity and
electronic changes in their σ-frameworks. To study the
amyloidogenic behavior of halogenated NFGAIL variants, we
used ThT fluorescence assay to study amyloid nucleation and
propagation, molecular modeling of the fluorinated side chains,
but also TEM and SAXS measurements to study the morphology
of resulting fibrils. Our kinetic data revealed a synergy between
the hydrophobic nature of incorporated Phe analogues and
respective aggregation kinetics in NFGAIL amyloid formation.
Also, we probed the role of aromatic-aromatic interactions in
NFGAIL self-assembly by a possible perturbation of π-stacking
geometries and, thus, in molecular self-recognition. Based on
our experimental data we suggest an amyloidogenic behavior
of these peptides independent from π-stacking geometries.
Furthermore, we found a remarkable experimental result given
by the elongated lag time of the difluorinated variant N-[3.5F]
Phe-GAIL, for which, as shown by molecular modeling, we
assume its enhanced polarity to act as a diametrical effect
towards the amyloid self-assembly process. TEM micrographs
revealed specific morphologies and diameters caused by
incorporation of fluorine and iodine but confirmed amyloid
Figure 6. Negative-staining transmission electron microscopy (TEM) images
of selected NFGAIL solutions in ammonium acetate buffer (10 mM, pH~7)
show the formation of amyloid fibrils. Samples: a) N-[4F]Phe-GAIL; [4 mM] b)
N-[3.5F]Phe-GAIL; [4 mM] c) N-[2.3.5.6F]Phe-GAIL; [3 mM] d) N-[2.3.5.6F]Phe-
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formation for all sequences. In addition, SAXS data obtained for
the native NFGAIL sequence and its fluorinated derivatives N-
[2.3.5.6F]Phe-GAIL and N-[2.3.5.6F]Phe-GAIL indicated the occur-
rence of ribbon-like structures that typically resemble amyloid
fibrils possessing similar dimensions. The aggregation kinetics
of NFGAIL reported herein and the underlying design principle
may play a crucial role for future design of amyloidogenic




1H, 13C and 19F NMR spectra (Figures S1–S12) were recorded at room
temperature using a JEOL ECX 400, a JEOL ECP 500 (JEOL, Tokyo,
Japan) or a Bruker AVANCE III 700 (700 MHz, Bruker). Chemical shifts
δ are reported in ppm with the solvent resonance as the internal
standard (CDCl3=7.26 ppm, CD3OD=3.31 ppm). HRMS were deter-
mined on an Agilent 6220 ESI-TOF MS instrument (Agilent
Technologies). For analysis, the MassHunter Workstation Software
VersionB.02.00 (Agilent Technologies) was used. Fmoc-L-amino
acids were purchased from ORPEGEN Peptide Chemicals GmbH
(Heidelberg, Germany). Fluorinated Fmoc-L-amino acids were
purchased from commercial sources as follows:Fmoc-[4F]Phe-OH
(VWR, Darmstadt, Germany), Fmoc-[3.5F]Phe-OH (ABCR, Karlsruhe,
Germany), Fmoc-[2.3.4.5.6F]Phe-OH (Oxchem, Wood Dale, USA).
Fmoc-[2.3.4.5.6F][4I]Phe-OH was kindly provided by Prof. Dr.
Pierangelo Metrangolo. Fmoc-[2.3.4.5.6F]Phe-OH was synthesized
according to literature.[19c]
Peptide synthesis
All peptides were synthesized according to standard Fmoc-
chemistry using preloaded Fmoc-Leu-NovaSyn®TGA[0.2 mmol/g]
resins. Standard couplings were performed in DMF with Fmoc-
amino acids and HOBt [1-hydroxybenzotriazole]/DIC [N,N’-diisocar-
bodiimide] in eight-fold excess with respect to the resin amount
and with double couplings of one hour coupling time. For coupling
of fluorinated amino acids, a protocol containing Fmoc-amino acid
with HOAt/DIC and COMU/DIPEA with double couplings of 1 h was
used. For subsequent capping of free amino groups with acetic
anhydride, a solution of Ac2O (10% (v/v) and DIPEA (10% (v/v) in
DMF (6 mL) was added in three batches. The reaction was then
shaken for 3*10 min. Afterwards, resins were washed with 6 mL
DMF (3*1 min) and 6 mL CH2Cl2 (3 x 1 min). In general, a mixture of
DBU [1,8-diazabicyclo[5,4,0] undec-7-en] and piperidine (2% each)
in DMF was used for Fmoc-deprotection (3*10 min); the resins
were washed between each step with DMF and CH2Cl2 (3*6 mL
each). Peptides were cleaved from the resin by treatment with TFA/
TIPS/H2O (90 :5 :5) [1 mL cleavage-cocktail per 50 mg resin] for 3 h
using sonication at room temperature. Then the resins were
washed thrice with 3 mL TFA and CH2Cl2, and excess of solvents
were removed by evaporation. Peptides were dried by lyophiliza-
tion before purification with preparative reversed phase HPLC. For
semi-preparative HPLC, all NFGAIL variants were dissolved in MeOH.
Purification of synthesized peptides was performed on a Knauer
low-pressure HPLC system (Knauer GmbH, Berlin, Germany) sold by
VWR, comprising a LaPrep Sigma preparative pump (LP1200), a
ternary low-pressure gradient, a dynamic mixing chamber, a 6-port,
3-channel injection valve with an automated preperative 10 mL
sample loop, a LaPrep Sigma standard 1-channel UV detector
(LP3101), a flow cell of 0.5 mm thickness and a 16-port LaPrep
Sigma fractionation valve (LP2016). A Kinetex RPC18 endcapped
(5 μM, 100 Å, 250*21.2 mm,
Phenomenex®) HPLC-column was used. A Security GuardTM PREP
Cartridge Holder Kit (21.20 mm, ID, Phenomenex®, USA) served as
pre-column. As eluents water and ACN, both containing 0.1% (v/v)
TFA were applied. HPLC runs were performed with a flow rate of
15.0 mL/min, UV detection occurred at 220 nm for respective
peptides. A linear gradient of 5–70% ACN+0.1% TFA was applied
within 18 min. Data analysis occurred with an EZChrom Elite-
Software (Version 3.3.2 SP2, Agilent). After separation, the purity of
the collected fractions was determined by analytical HPLC. Fractions
with sufficient purity were combined and ACN was removed by
rotary evaporation. Lyophilization of the remaining aqueous
solution yielded the pure product. Analytical HPLC was carried out
on a Chromaster 600 bar DAD-System with CSM software (VWR/
Hitachi). The system works with a low-pressure gradient containing
a HPLC-pump (5160) with a 6-channel solvent degaser, an
organizer, an autosampler (5260) with a 20 μL sample loop, a
column oven (5310) and a diode array flow detector (5430) with a
high pressure semi-micro flow cell. A Purospher®STAR RP  C18 end-
capped (2 μM, 50*2.1 mm, Merk, Deutschland) UHPLC column was
used. Water and ACN, both containing 0.1% (v/v) TFA were applied
as eluents. A flow rate of 0.6 mL/min was used and the column was
heated to 24 °C. UV-detection occurred at 220 nm for respective
peptides. A linear gradient of 5–70% ACN+0.1% TFA within
10 min or 5–100% ACN+0.1% TFA within 18 min was applied for
all NFGAIL variants. The data were analyzed with EZ Chrom ELITE
software (version 3.3.2, Agilent). All peptides sequences were
obtained as white lyophilized powder: HRMS: NFGAIL=HRMS (ESI-
TOF) m/z: [M+H]+ calcd. for C30H48N7O8 634.3564; found 634.3627.
N-[4F]Phe-GAIL=HRMS (ESI-TOF) m/z: [M+H]+ calcd. for
C30H47FN7O8 652.3470; found: 652.3475. N-[3,5F]Phe-GAIL=HRMS
(ESI-TOF) m/z: [M+H]+ calcd. for C30H46F2N7O8 670.3375; found:
670.3392. -[2.3.4.5.6F]Phe-GAIL=HRMS (ESI-TOF) m/z: [M+H]+
calcd. for C30H44F4N7O8 706.3187; found: 706.3196. N-[2.3.4.5.6F]Phe-
GAIL=HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C30H43F5N7O8
724.3093; found: 724.3100. N-[2.3.4.5.6F][4I]Phe-GAIL=HRMS (ESI-
TOF) m/z: [M+H]+ calcd. for C30H43F4IN7O8 832.2154; found:
832.2205.
HPLC assay for estimation of hydrophobicity
The protocol for the RP-HPLC assay was previously established by
our group.[15d] The retention times of Fmoc-[4F]Phe-OH, Fmoc-[3,5F]
Phe-OH, Fmoc-[2.3.4.5.6F]Phe-OH, Fmoc-[2.3.4.5.6F]Phe-OH, Fmoc-
[2.3.4.5.6F][4I]Phe-OH and Fmoc-protected native amino acids as
reference were determined on a C18 column (Capcell C18, 5 μm).
The samples were dissolved in 1 mL of a mixture of 40% (v/v) ACN
in 60% (v/v) Milli-Q-water containing 0.1% TFA and filtered over a
syringe filter with 0.2 μm pore size. A linear gradient from 40 to
70% ACN over 30 min was applied at room temperature and all
experiments were performed in triplicates. The vdW volumes of the
side chains were calculated according to Zhao et al.[23b]
Thioflavin T fluorescence assay
As a general procedure, stock solutions of NFGAIL variants were
prepared by dissolving the purified peptides in 1,1,1,3,3,3-hexa-
fluoro-propan-2-ol [HFIP] (3–4 mL) and further sonication for 15 min
to dissolve all preformed aggregates. Aliquots of these stock
solutions were dried and then redissolved in ammonium acetate
buffer (10 mM, pH~7), containing 20 μM ThT. The buffer containing
ThT was previously filtered over a nylon syringe filter with 0.2 μm
pore size. After dissolution, the sample was sonicated for 30 s,
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Sigma-Aldrich), sealed to prevent evaporation and placed in an
Infinite M200 plate reader (Tecan Nordic AB, Molndal, Sweden). ThT
fluorescence (λex=420 nm, λem=485 nm, Z-position: 15173 nm
[manual], gain: 80 [manual], lag time: 0 μs, integration time: 20 μs)
was measured every 10 min. The plates were shaken for 2 s
(amplitude: 2 mm, frequency: 280.8 rpm) before each measurement
and incubated at 37 °C during the whole experiment. The
fluorescence intensity at 485 nm was normalized with respect to its
maximum value.
Transmission electron microscopy
Aliquots (5 μL) of the aqueous amyloid samples were applied to a
Formvar/carbon-covered copper grid (400 mesh, PLANO GmbH,
Wetzlar) which was hydrophilized by 60 s glow discharging at 8 W
in a BALTEC MED 020 device directly before use. After 45 s of
sedimentation, excess liquid was removed with blotting paper and
the sample was stained for 45 s using a solution of phosphotungs-
tic acid (PTA, 1%). After excess PTA was removed with blotting
paper, the grid was allowed to air dry for at least 30 min. The grid
was then transferred to a Talos L120 C transmission electron
microscope (FEI Company, Oregon) equipped with a LaB6 electrode
operating at an acceleration voltage of 120 kV. Image data were
recorded using a 4k×4k Ceta CMOS camera.
Computational methods
Calculation of MlogP values according to Moriguchi et al. were
carried out by using MedChem DesignerTM (Simulations Plus Inc.,
Lancaster, USA).[24,44] All QM density-functional calculations were
carried out using Gaussian 16. Geometry optimizations were
performed on the B3LYP/6-31(d,p) level of theory; interaction
energies were computed from MP2/cc-pVTZ single energy calcu-
lations of the optimized structures. All MP2 level computations
were corrected for the basis set superposition error using the
counterpoise method. Electrostatic potential plots were generated
from B3LYP/6-31(d,p) geometry optimized structures by mapping
the resulting electrostatic potentials on isosurfaces from volumetric
Gaussian density maps generated by the QuickSurf algorithm in
VMD.
Small-angle X-ray scattering
The SAXS of the samples were performed with a SAXSess camera
(Anton Paar, Austria). This Kratky type of camera is attached to a
laboratory X-ray generator (PW3830, PANalytical), and is operated
with a fine focus glass X-ray tube at 40 kV and 40 mA (CuKα, λ=
0.1542 nm). A focusing multi-layer optic and a block collimator
provide a monochromatic primary beam with low background.
Samples were filled in a reusable vacuum tight flow cell sample
holder. SAXS data (intensity as a function of the scattering vector)
was recorded for 600 s (60*10 s) with a Mythen detection system
(Dectris Inc.) in a q-range of 0.1 to 7.0 nm  1 (Anton Paar). The
scattering vector is defined in terms of the scattering angle, θ and
the wavelength, λ of the radiation, thus q=4/4λ sin(θ). For clarity,
the angle between incident and scattered beam is 2θ. The two-
dimensional intensity data was converted to one-dimensional data
with SAXSQuant software (Anton Paar). The temperature of 21 °C
was controlled with a TCS 120 sample holder (Anton Paar) with an
accuracy of �0.2 °C. A reusable capillary was used for all measure-
ments to attain the same scattering volume and background
contribution. The resulting scattering curves were corrected for the
contribution of the suspension medium (water) and the capillary.
Furthermore, the data was deconvoluted (desmeared) using the
length profile of the primary beam[45] with SAXSQuant (Anton Paar
AG, Graz). Curve fits using the parallelepiped structure model were
performed with the open access SAXS data interpretation program
SASfit.[46]
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